Free Trial

IQ-AI (IQAI) Competitors

IQ-AI logo
GBX 1.48 +0.08 (+5.71%)
(As of 12/20/2024 12:01 PM ET)

IQAI vs. COG, INHC, FDBK, DVRG, TRLS, SENS, EMIS, CRW, INS, and KOO

Should you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

IQ-AI vs.

IQ-AI (LON:IQAI) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

Cambridge Cognition has a net margin of -10.07% compared to IQ-AI's net margin of -77.52%. Cambridge Cognition's return on equity of -74.36% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Cambridge Cognition -10.07%-74.36%-0.30%

In the previous week, Cambridge Cognition had 2 more articles in the media than IQ-AI. MarketBeat recorded 2 mentions for Cambridge Cognition and 0 mentions for IQ-AI. Cambridge Cognition's average media sentiment score of 0.94 beat IQ-AI's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company Overall Sentiment
IQ-AI Neutral
Cambridge Cognition Positive

IQ-AI has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Cambridge Cognition received 99 more outperform votes than IQ-AI when rated by MarketBeat users. However, 66.67% of users gave IQ-AI an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%

35.2% of Cambridge Cognition shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

IQ-AI has higher earnings, but lower revenue than Cambridge Cognition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K6.10N/AN/AN/A
Cambridge Cognition£13.08M1.03-£1.32M-£0.04-800.00

Summary

Cambridge Cognition beats IQ-AI on 8 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IQAI vs. The Competition

MetricIQ-AIHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.28M£196.58M£5.14B£1.89B
Dividend Yield17.30%6.94%5.09%5.46%
P/E Ratio-13.67540.3890.131,843.16
Price / Sales6.10285.021,117.09389,641.00
Price / Cash10.2547.1443.1028.69
Price / BookN/A5.074.782.78
Net IncomeN/A-£8.11M£120.31M£155.66M
7 Day Performance-7.50%-0.95%-1.92%-2.01%
1 Month Performance-7.50%5.83%13.65%21.46%
1 Year Performance-63.00%6.32%28.34%29.47%

IQ-AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IQAI
IQ-AI
N/AGBX 1.48
+5.7%
N/A-63.0%£3.28M£538,190.00-13.676Gap Up
COG
Cambridge Cognition
N/AGBX 30.40
-0.3%
N/A-37.9%£12.75M£13.08M-760.0080News Coverage
Gap Up
High Trading Volume
INHC
Induction Healthcare Group
N/AGBX 8.67
-3.7%
N/A-61.5%£8.14M£13.65M-300.0074Gap Down
FDBK
Feedback
N/AGBX 17
-4.2%
N/A-75.9%£2.27M£1.18M-71.0024
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.56
-2.6%
N/A-82.9%£904,000.00£35,000.00-19.1731Gap Down
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.4374 of 5 stars
GBX 2,250
-2.2%
GBX 2,700
+20.0%
+22.9%£795.15M£189.27M8,846.15734
INS
Instem
N/AGBX 830
flat
N/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.2888 of 5 stars
GBX 167.25
-1.3%
GBX 585
+249.8%
-45.5%£61.01M£54.17M1,412.50478Positive News

Related Companies and Tools


This page (LON:IQAI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners